I-PASS Method on Handover QualityNCT07561762
THE I-PASS COMMUNICATION METHOD ON NURSE PERCEPTION OF HANDOVER QUALITY
A study testing Training I-PASS handoff bundle in people with I-PASS Method on Handover Quality, run by Universitas Padjadjaran at 1 site in Indonesia.
Trial summary
The goal of this non-clinical study is to determine whether the I-PASS communication method influences the improvement of handover quality among nurses. The main questions it aims to answer are: What are the perceptions of handover quality prior to implementing the I-PASS method? What are the perceptions of handover… Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- I-PASS Method on Handover Quality
- What is being tested?
- Training I-PASS handoff bundle
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 46 participants
- Where
- 1 siteIndonesia
- Study dates
- 1 Apr 2026to 15 Apr 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- General practitioner nurses who working in the internal ward
- General practitioner nurses with a minimum of 6 months of the clinical experience
Who cannot join
- Clinical nurse manager / leader who did not provide nursing care (e.g Head nurse)
- Nurses on leave
Trial locations and contacts
1 site in 1 country.
Indonesia1 site
Welas Asih General Hospital West Java Province
Bandung, West Java, 40191
About this study
Official title: THE EFFECTIVENESS OF THE I-PASS COMMUNICATION METHOD ON NURSE PERCEPTION OF HANDOVER QUALITY IN THE INPATIENT WARD OF WELAS ASIH HOSPITAL, WEST JAVA PROVINCE
The goal of this non-clinical study is to determine whether the I-PASS communication method influences the improvement of handover quality among nurses. The main questions it aims to answer are:
What are the perceptions of handover quality prior to implementing the I-PASS method? What are the perceptions of handover quality after using the I-PASS method? How do nurse characteristics (gender, age, education, employment status, length of service, and clinical nurse level) affect the improvement of handover quality perceptions when using the I-PASS method? What is the implementation retention of the I-PASS communication method? Is there a significant effect of the I-PASS communication method on nurses' perceptions of handover quality?
Read more
Participants will:
Participate in training sessions regarding the I-PASS communication method. Implement the I-PASS method during handover processes for two weeks. Complete questionnaires to assess handover quality.
- Conditions
- I-PASS Method on Handover Quality
- Being tested
- Training I-PASS handoff bundle
- Keywords
- I-PASS, Communication, Handover Quality, Patient Safety, Nurse
- Medical subject headings
- Communication
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Training I-PASS handoff bundleOther
The intervention proceeds of Training I-PASS handoff bundle in three phases: preparation, training, and evaluation. First, eligible nurses are recruited, provided with informed consent, and grouped by shifts. After a baseline assessment, participants undergo two 90-minute training sessions over two weeks. Next, the I-PASS method is implemented for 14 days, with compliance monitored through direct shift-based observations and checklists. Handover quality is measured via the Handover Evaluation Scale (HES) at three intervals: pre-test (baseline), mid-point (week two), and post-test (week three). Continuous researcher monitoring ensures protocol fidelity throughout the process.
| Study group | Role | What they receive |
|---|---|---|
| Training I-PASS handoff bundle | Experimental | Partisipant in experimental arms will receive I-PASS handoff bundle into daily nursing process for 2 weeks Receives: Other: Training I-PASS handoff bundle |
| SBAR | No intervention | The control group continues to utilize the hospital's existing standard operating procedure, the SBAR (Situation, Background, Assessment, Recommendation) method, observed two weeks not training I-PASS handoff bundle |
What is being measured
The primary outcome is the main question the study is designed to answer.
Handover Quality
Handover quality measure by the handover evaluation scale instrument
Measured: two weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 May 2026
- Study start1 Apr 2026
- Primary completion15 Apr 2026
- Study completion15 Apr 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for I-PASS Method on Handover QualityStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 46 participants (actual)
Sponsor and investigators
- Lead sponsor
- Universitas Padjadjaran
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Agnes Stephania Penu, Universitas Padjadjaran
- Investigators
- Agnes Stephania Penu, BSN, MSc, RN, Principal investigator, Faculty of Nursing, Universitas Padjadjaran
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07561762
- Sponsor's protocol ID
- NURS-202604.01
- Status last verified
- Mar 2026
- First submitted
- 25 Apr 2026
- Last updated
- 1 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: This research considers ethical values such as autonomy, confidentiality, beneficence, non- maleficence and justice
Study at a glance
From the registry record, last updated by the sponsor on 1 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- THE EFFECTIVENESS OF THE I-PASS COMMUNICATION METHOD ON NURSE PERCEPTION OF HANDOVER QUALITY IN THE INPATIENT WARD OF WELAS ASIH HOSPITAL, WEST JAVA PROVINCE
- ClinicalTrials.gov ID
- NCT07561762
- Acronym / sponsor ID
- NURS-202604.01
- Conditions
- I-PASS Method on Handover Quality
- Keywords
- I-PASS, Communication, Handover Quality, Patient Safety, Nurse
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 46 participants (actual)
- Lead sponsor
- Universitas PadjadjaranUniversity, hospital or other
- Study start
- 1 Apr 2026 (actual)
- Primary completion
- 15 Apr 2026 (actual)
- Study completion
- 15 Apr 2026 (actual)
- First posted
- 1 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this non-clinical study is to determine whether the I-PASS communication method influences the improvement of handover quality among nurses. The main questions it aims to answer are:
What are the perceptions of handover quality prior to implementing the I-PASS method? What are the perceptions of handover quality after using the I-PASS method? How do nurse characteristics (gender, age, education, employment status, length of service, and clinical nurse level) affect the improvement of handover quality perceptions when using the I-PASS method? What is the implementation retention of the I-PASS communication method? Is there a significant effect of the I-PASS communication method on nurses' perceptions of handover quality?
Participants will:
Participate in training sessions regarding the I-PASS communication method. Implement the I-PASS method during handover processes for two weeks. Complete questionnaires to assess handover quality.
Study design
- Primary purpose
- Health services research
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Training I-PASS handoff bundle | Experimental | Other: Training I-PASS handoff bundlePartisipant in experimental arms will receive I-PASS handoff bundle into daily nursing process for 2 weeks |
| SBAR | No intervention | –The control group continues to utilize the hospital's existing standard operating procedure, the SBAR (Situation, Background, Assessment, Recommendation) method, observed two weeks not training I-PASS handoff bundle |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (2 listed)
- General practitioner nurses who working in the internal ward
- General practitioner nurses with a minimum of 6 months of the clinical experience
Key exclusion criteria (2 listed)
- Clinical nurse manager / leader who did not provide nursing care (e.g Head nurse)
- Nurses on leave
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Training I-PASS handoff bundleThe intervention proceeds of Training I-PASS handoff bundle in three phases: preparation, training, and evaluation. First, eligible nurses are recruited, provided with informed consent, and grouped by shifts. After a baseline assessment, participants undergo two 90-minute training sessions over two weeks. Next, the I-PASS method is implemented for 14 days, with compliance monitored through direct shift-based observations and checklists. Handover quality is measured via the Handover Evaluation Scale (HES) at three intervals: pre-test (baseline), mid-point (week two), and post-test (week three). Continuous researcher monitoring ensures protocol fidelity throughout the process. | Other | Training I-PASS handoff bundle |
Primary outcome
Handover Quality
Time frame: two weeks
Handover quality measure by the handover evaluation scale instrument
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 May 2026.
- Individual participant dataSharing planned: No. This research considers ethical values such as autonomy, confidentiality, beneficence, non- maleficence and justice
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Agnes Stephania Penu, BSN, MSc, RN principal investigator
Faculty of Nursing, Universitas Padjadjaran
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Training I-PASS handoff bundle in people with I-PASS Method on Handover Quality, run by Universitas Padjadjaran at 1 site in Indonesia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 1 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Indonesia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Handover Quality (time frame: two weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 May 2026.